Yes some one has faith and someone is taking profit or loss. Let's hope it's no someone with inside info selling.
Printable View
Yes some one has faith and someone is taking profit or loss. Let's hope it's no someone with inside info selling.
Harrie and others
I too am a longterm ATM investor who relies on fundamental analysis and doesn’t either understand or feel a need for TA. Like MAC I am not worried by the short term downturn in the SP.
I bought up quite big when the A2M share price was ranging between about 4c and 16c because from my reading I was absolutely certain the science behind A2 was correct and incontrovertible, and sooner or later it would be proved so.
There aren’t many investor forums fortunate enough to have a Bible. Any serious investor in ATM needs to read and have a copy of Keith Woodford’s book “Devil in the Milk”. It explains in layman’s terms the history and science behind the A1-A2 dispute, and really is the Bible. Get the second edition, which has updates on the scientific research. What’s remarkable about it is that the “scientists” (and there aren’t many) who try to dispute the A2 hypothesis have not, to my knowledge, succeeded in finding any fault at all in Woodford’s book. It stands undisputed, and it’s a good read.
It’s clear from my reading of this thread that a lot of members have not read the book. They should, before they start criticising the company’s strategy or – worse still – suggesting the science behind A2 isn’t sound.
So first there’s the book. Second, there’s Woodford’s blogsite <http://keithwoodford.wordpress.com/feed/> where he posts frequent updates on new scientific trials examining the A2 hypothesis. Again he explains them in language we can all understand. And the interesting thing here is that although there’s stacks of research being done round the world, none of it is CONTRADICTING the basic theory behind A2. It’s all pointing in the same direction, that A1 is harmful - even demonstrating links between A1 and autism and SIDS for example. A few days ago he posted on his website and on the NZ Farmer website and in the Sunday Star Times an article under the heading "A1 beta-casein a threat to dairy industry". Now you'd think that if Fonterra or Dairy NZ had factual material to respond to a headline like that, they'd have done so by now. But to my knowledge they haven't. Because they can't.
And finally, the Australian media are carrying lots of stories about the A1-A2 debate. So a google alert should bring up plenty of anecdotal accounts of consumers finding benefits from switching to A2. And interestingly, the mainstream dairy industry (eg Dairy Australia and the Australian Food Safety Authority) have virtually given up trying to dispute these things, except by trotting out the conclusions of reports written at least six years ago when there was far less clinical scientific proof of the A2 case, saying there still isn’t “absolute proof”. They’ll be saying this till the cows come home.
could be last bulk selling before report come out this thursday, and buyer think at this price is de-risk.
Wow that's a big call by both parties
According to post 1603 from Joshuatree, that can only be any one of the top 3 holders, although the NZ central securities depository probably contains a number of fund managers.
At a cost of over $5 mio the buyer would probably be a fund manager either already in there or a new enrant into the a2 story currently very short on the stock.
Be interesting to see a new chart (just for interest)
A nice surprise. Ive just found a contract note from Craigs which came thru @ 8 pm, my low buy of 63c got hit mmmh so will ask broker tomorrow about where the other 99 plus % went..
OK here is a theory
News has got out that the FY14 results are likely to show growth numbers but not as good as what was hoped for.
Some broker becomes impatient and needs to take some brokerage, so looks at exiting and moving on to something like a SPK which is showing a future growth path and increasing dividends. Easy story to sell to punters or the less informed.
Buyer becomes aware of long term advantages, has done research into future demand for milk, and adds the bonus of evidence coming through scientifically for A2, Most likely a Kiwisaver fund, and negotiates a bargain price of 0.63. Both are as happy as sandboys